HOME >> BIOLOGY >> NEWS
Study Shows First Significant Genetic Evidence For Schizophrenia Susceptibility

A 15-year study in more than 100 families and 1,000 subjects provides the first reliable evidence of genetic susceptibility to schizophrenia, within a stretch of DNA on human chromosome 13. The association of DNA with the susceptibility to the disease, reported by a Johns Hopkins-led international team, is the first such linkage to meet stringent statistical standards.

"Finding an actual gene for schizophrenia susceptibility will be like finding a particular house in a large city," says genetic epidemiologist Ann Pulver, Sc.D., who led the study; "But we've found the city. It's a first step, and an exceedingly important one."

The study, reported in this month's Nature Genetics, also suggests that different genes may be responsible for the disease in different families.

Most experts agree schizophrenia is a condition influenced by both genes and environment. In studies of identical twins, for example, where only one twin develops schizophrenia, the other twin has a 46 percent chance of having the disorder. That's higher than the 1 percent rate for the general population but not the near-100 percent expected if genes are the only cause. "It's not the case that you have the gene, you have the disease,'" says Pulver. "The genetic effect is one of susceptibility to schizophrenia."

Unlike such inherited disorders as sickle cell anemia, which stems from mutation in a single gene, susceptibility to schizophrenia involves more than one gene, Pulver says, as well as environmental factors.

In the new study, the researchers carefully evaluated and took blood samples from 54 patients diagnosed with either schizophrenia or with schizoaffective disorder, a type of schizophrenia with elements of depression, mania or both. Researchers also evaluated and took samples from patients' extended families.

They extracted blood cell DNA and scanned it with molecular probes, looking for particular sequence
'"/>

Contact: Marjorie Centofanti
mcentofanti@jhmi.edu
(410) 955-8725
Johns Hopkins Medical Institutions
1-Sep-1998


Page: 1 2 3

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study suggests cell-cycle triggers might be cancer drug targets
9. Study narrows search for genes placing men at increased risk for prostate cancer
10. Study links high carbohydrate diet to increased breast cancer risk
11. Study explains spatial orientation differences between sexes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... SAN FRANCISCO (PRWEB) , ... December 04, 2018 ... ... for life sciences and diagnostics companies, announces the placement of Michael Mercer at ... the commercial business strategy, Mr. Mercer will be based at Karius' headquarters in ...
(Date:11/29/2018)... ... 29, 2018 , ... ACEA Biosciences , now a ... Research Center for Cell Manufacturing Technologies (CMaT). CMaT is a consortium ... technologies for the consistent, scalable and low-cost production of high-quality living therapeutic cells. ...
(Date:11/27/2018)... ... November 27, 2018 , ... Victrex has designed a new ... broader range of usage temperature compared to existing polymers such as PCTFE. At ... CTâ„¢ 200 for dynamic sealing applications where gases such as LNG* are stored ...
Breaking Biology News(10 mins):
(Date:11/5/2018)... ... November 05, 2018 , ... ... company backed by Siemens Healthineers and several healthcare VC firms announces at Distributed ... and making a history by purchasing tokens and obtaining its first radiology interpretations, ...
(Date:11/5/2018)... ... 2018 , ... 2Blades has completed a non-exclusive license agreement ... technology for applications in advancing research in epigenetic technology. , 2Blades holds ... 2009, the efficacy of TAL effector-based DNA targeting has been established rapidly in ...
(Date:11/3/2018)... DURHAM, N.C. (PRWEB) , ... November 01, 2018 , ... ... recognized by Inc. Magazine as one of the fastest-growing private companies in the United ... the Inc. 5000 list ranks private companies based on percentage revenue growth over the ...
(Date:10/31/2018)... ... October 30, 2018 , ... Myoscience, Inc. announced ... Campbell Clinic in Memphis, Tennessee. This study enrolled 125 patients and compares ... for managing pain after total knee replacement surgery (TKA). , The Myoscience iovera° ...
Breaking Biology Technology:
Cached News: